Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation

Lung Cancer, 06/08/2012

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) therapy might be the treatment of choice for metastatic brain tumors in non–small cell lung cancer patients harboring an activating EGFR mutation.

Print Article Summary Cat 2 CME Report